Definitive Contract 75N93022C00047
Award Date
8/8/22
Potential Completion Date
8/7/23
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Melax Technologies Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price definitive contract for $300,000 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Innov8Ai, a for-profit small business, to advance the agency's mission through research and development. The contract is associated with the Small Business Innovation Research Program Phase I solicitation to capture medical misinformation in social media for targeted interdiction using an...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a...
This definitive contract award of $299,993 by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases is for the prime contractor The Simple VUE LLC to deliver digital tools against misinformation about infectious disease treatments and vaccines. The award is associated with the National Institutes of Health and Centers for Disease Control and Prevention solicitation for Small Business Innovation Research contracts seeking...
This federal contract award to Neovaxsyn Inc., a minority-owned small disadvantaged business, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The $300,000 firm fixed-price contract supports the development of a next-generation immunoprevention platform against HIV-1, with a final completion date of October 31, 2025. The contract was awarded under the Small Business Innovation Research (SBIR) program, which...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This $300,000.00 Firm Fixed Price contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Melax Technologies Inc., a small business, to conduct research and development on an Integrated Analysis of Heterogeneous COVID-19 Datasets Using Knowledge Graph under the SBIR Program Phase I. As a subcontractor, the University of California, San Diego (UCSD) will support tasks such as designing...
This is a $300,000 firm fixed price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Neovaxsyn Inc., a minority-owned small disadvantaged business. The contract is for research and development to utilize nanoparticles to deliver MPER-based immunogens and elicit broadly neutralizing antibodies against the HIV-1 virus in order to develop a protective vaccine. This contract was awarded under the Small...
Gryphon Scientific, LLC was awarded a firm fixed price definitive contract valued at $299,964 by the National Institutes of Health National Institute of Allergy and Infectious Diseases. This contract is set aside for total small businesses. The contract is for a Systematic Understanding and Elimination of Misinformation Online project to be completed by August 7, 2023. This award stems from a July 2021 pre-solicitation notice from NIH and CDC seeking Small Business Innovation Research contract...
This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Techwave International, Inc., a self-certified small disadvantaged business. The contract is part of the Small Business Innovation Research (SBIR) program under Topic Area 045, with a potential value of $224,689.92. The contract does not have a set-aside designation and was awarded on May 5, 2017, with a completion date of July 31, 2018. The...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, has awarded a Small Business Innovation Research (SBIR) Phase I Definitive Contract with a ceiling value of $299,326.00 to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract requires Lynntech to design and develop a novel "3IN1" approach to efficiently collect samples (blood, sputum, urine) in field locations to support surveillance...